BL
WST icon

Balentine LLC’s West Pharmaceutical WST Stock Holding History

Balentine LLC’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,625
Closed -$643K – 582
2024
Q1 		$643K Buy
1,625
+41
+3% +$15.2K 0.02% 248
2023
Q4 		$558K Buy
1,584
+568
+56% +$201K 0.02% 265
2023
Q3 		$381K Buy
1,016
+43
+4% +$16.6K 0.01% 321
2023
Q2 		$372K Buy
973
+290
+42% +$104K 0.01% 337
2023
Q1 		$237K Buy
+683
New +$200K 0.01% 472
2022
Q2 		– Sell
-734
Closed -$301K – 712
2022
Q1 		$301K Buy
+734
New +$287K 0.01% 429
2020
Q3 		– Sell
-15
Closed -$3K – 852
2020
Q2 		$3K Buy
+15
New +$2.95K ﹤0.01% 819
2019
Q3 		– Sell
-22
Closed -$3K – 825
2019
Q2 		$3K Buy
+22
New +$2.6K ﹤0.01% 605
2018
Q1 		– Sell
-61
Closed -$6K – 525
2017
Q4 		$6K Hold
61
– – ﹤0.01% 504
2017
Q3 		$6K Hold
61
– – ﹤0.01% 506
2017
Q2 		$6K Hold
61
– – ﹤0.01% 484
2017
Q1 		$5K Buy
+61
New +$5.1K ﹤0.01% 474

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Balentine LLC's WST Position: Q2 2024 in Review

Balentine LLC sold out of West Pharmaceutical (WST) in Q2 2024, closing a stake of 1,625 shares — an estimated $643K sold.

Balentine LLC first reported a position in WST in Q1 2017 and held it in 12 quarters. The position peaked at $643K in Q1 2024. 776 funds tracked by Wall St. Rank hold WST as of Q2 2024.

  • Balentine LLC reported no remaining West Pharmaceutical position as of Q2 2024 after selling out during the quarter.
  • Balentine LLC sold 1,625 West Pharmaceutical shares in Q2 2024, an estimated $643K.
  • Balentine LLC first reported a position in West Pharmaceutical in Q1 2017 and held it in 12 quarters.
  • Balentine LLC's West Pharmaceutical position peaked at $643K in Q1 2024.
  • 776 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2024.

Based on Balentine LLC's 13F filing for Q2 2024, filed 7 Aug 2024.